An efficient and stereoselective synthesis of (3S,4R)-(-)-trans-4- (4′-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine

Tetrahedron Asymmetry

Volumn 22, Issue 1, 2011, Pages 1-3

  Somaiah, Sripathi ^a   Sashikanth, Suthrapu ^a   Raju, Veeramalla ^a   Reddy, Karnati Venugopal ^b  

^a Srini Pharmaceuticals Ltd   (India)

^b OSMANIA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 (4 LUOROPHENYL) ACRYLOYL] 4 PHENYLOXAZOLIDIN 2 ONE; 3 ETHOXYCARBONYL 4 (4' FLUOROPHENYL) N METHYLPIPERIDINE 2,6 DIONE; 4 (4' FLUOROPHENYL) 3 HYDROXYMETHYL N METHYLPIPERIDINE; PAROXETINE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC SYNTHESIS; CHEMICAL REACTION; DRUG SYNTHESIS; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 79951810377     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2010.12.020     Document Type: Article

References (27)

1. (a) Mathis, C. A.; Gerdes, J. M.; Enas, J. D.; Whitney, J. M.; Taylor, S. E.; Zhang, Y.; McKenna, D. J.; Havlik, S.; Peroutka, S. J. J. Pharm. Pharmacol. 1992, 44, 801-805;
2. For a review, see: (b) Dechant, K. L.; Clissold, S. P. Drugs 1991, 41, 225-253.
3. Robertson, D. W.; Krushinski, J. H.; Fuller, R. W.; Leander, J. D. J. Med. Chem. 1988, 31, 1412-1417.
4. Gunasekara, N. S.; Noble, S.; Benfield, P. Drugs 1998, 55, 85-120.
5. Drugs Future 1986, 11, 112.
6. For other asymmetric synthesis of paroxetine, see: (a) Cossy, J.; Mirguet, O.; Gomez Pardo, D.; Desmurs, J. R. Tetrahedron Lett. 2001, 42, 5705-5707;
7. (b) Liu, L. T.; Hong, P. C.; Huang, H. L.; Chen, S. F.; Wang, C. L. J.; Wen, Y. S. Tetrahedron: Asymmetry 2001, 12, 419-426;
8. (c) Johnson, A. J.; Curtis, M. D.; Beak, P. J. Am. Chem. Soc. 2001, 123, 1004-1005;
9. (d) Yu, M. S.; Lantos, I.; Peng, Z. Q.; Yu, J.; Cacchio, T. Tetrahedron Lett. 2000, 41, 5647-5651;
10. (e) Amat, M.; Bosch, J.; Hidalgo, J.; Canto, M.; Pérez, M.; Llor, N.; Molins, E.; Miravitlles, C.; Orozco, M.; Luque, J. J. Org. Chem. 2000, 65, 3074-3084;
11. (f) Shih, K. S.; Liu, C. W.; Hsieh, Y. J.; Chen, S. F.; Ku, H.; Liu, L. T.; Lin, Y. C.; Huang, H. L.; Wang, C. L. J. Heterocycl. 1999, 51, 2439-2444;
12. (g) Murthy, K. S. K.; Rey, A. W. WO Patent 9907680, 1999; Chem. Abstr. 1999, 130, 182361.;
13. (h) Patil, V. D.; Viswanathan, C. L. Indian Drugs 1998, 35, 686-692;
14. (i) Kreidl, J.; Czibula, L.; Deutschné, J.; Werkné Papp, E.; Nagyné Bagdy, J.; Dobay, L.; Hegedus, I.; Harsanyi, K.; Borza, I. WO Patent 9801424, 1998; Chem. Abstr. 1998, 128, 127941.;
15. (j) Sugi, K.; Itaya, N.; Katsura, T.; Igi, M.; Yamazaki, S.; Ishibashi, T.; Yamaoka, T.; Kawada, Y.; Tagami, Y. Eur. Patent 0812827 A1, 1997; Chem. Abstr. 1998, 128, 75308.;
16. (k) Adger, B. M.; Potter, G. A.; Fox, M. E. WO Patent 9724323, 1997; Chem. Abstr. 1997, 127, 149075.;
17. (l) Zepp, C. M.; Gas, Y.; Heefner, D. L. US Patent 5,258,517, 1993; Chem. Abstr. 1994, 120, 217289.;
18. (m) Willcocks, K.; Barnes, R. D.; Rustidge, D. C.; Tidy, D. J. D. J. Labelled Compd. Radiopharm. 1993, 33, 783-794;
19. (n) Stemp, J. A.; Miller, D.; Martin, R. T. Eur. Patent 0190496, 1985.
20. (a) Engelstoft, M.; Hansen, J. B. Acta Chem. Scand. 1996, 50, 164-169;
21. (b) Christensen, J. A.; Squires, R. F. US Patent 4,007,196; Chem. Abstr. 1974, 81, 152011.
22. (a) Palomo, J. M.; Fernandez-Lorente, G.; Mateo, C.; Fernandez-Lafuente, R.; Guisan, J. M. Tetrahedron: Asymmetry 2002, 13, 2375-2381;
23. (b) Gledhill, L.; Kell, C. M. WO Patent 98/02556.;
24. (c) Zepp, C. M.; Gao, Y.; Heefner, D. L. WO Patent 94/ 03428.;
25. (d) Curzons, A. D.; Powell, L. W.; Keay, A. M. WO Patent 93/22284.
26. Damon, R. E. U.S. Patent 4,876,280, 1989.
27. Faruk, E. A.; Martin, R. T. U.S. Patent 4,902,801, 1990.